Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose

American Journal of Public Health

Volumn 99, Issue 5, 2009, Pages 788-791

  Doe Simkins, Maya ^a   Walley, Alexander Y ^b,c,d   Epstein, Andy ^c   Moyer, Peter ^d,e  

^a Boston Public Health Commissions   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e Boston Emergency Medical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; METHADONE; NALOXONE; OPIATE;

DRUG OVERDOSE; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; MEDICAL EDUCATION; MEDICAL INSTRUMENTATION; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; OVERDOSE; PROGRAM EVALUATION; RISK FACTORS;

EID: 68949105844     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.146647     Document Type: Review

References (26)

1. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15:618-627.
2. Centers for Disease Control and Prevention. Unintentional opiate overdose deaths - King County, Washington, 1990-1999. MMWR Morb Mortal Wkly Rep. 2000;49:636-640.
3. Centers for Disease Control and Prevention. Heroin overdose deaths - Multnomah County, Oregon, 1993-1999. MMWR Morb Mortal Wkly Rep. 2000;49:633-636.
4. Shah NG, Lathrop SL, Reichard RR, Landen MG. Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction. 2008;103:126-136.
5. Paulozzi LJ. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006;96:1755-1757.
6. Fernandez W, Hackman H, McKeown L, Anderson T, Hume B. Trends in opioid-related fatal overdoses in Massachusetts, 1990-2003. J Subst Abuse Treat. 2006;31:151-156.
7. Massachusetts Department of Public Health Bureau of Substance Abuse Services. Fatal opioid overdose trends continue. Prevention News [serial online]. 2008;2. Available at: http://170.63.97.68/Eeohhs2/docs/ dph/substance-abuse/prevention-newsletter-2008spring.rtf. Accessed September 21, 2008.
8. Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction. 2005;100:1823-1831.
9. Ashton H, Hassan Z. Intranasal naloxone in suspected opioid overdose. Emerg Med J. 2006;23:221-223.
10. Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005;29:265-271.
11. Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutso giannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust. 2005;182:24-27.
12. Loimer N, Hofmann P, Chaudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict. 1994;29:819-827.
13. Barton ED, Ramos J, Colwell C, Benson J, Baily J, Dunn W. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care. 2002;6:54-58.
14. Strang J, Manning V, Mayet S, et al. Family carers and the prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone. Drugs Educ Prev Policy; 2008;15:211-218.
15. Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme [published online ahead of print May 23, 3008]. Int J Drug Policy. PMID: 18502635.
16. Bigg D. Data on take home naloxone are unclear but not condemnatory. BMJ. 2002;324:678.
17. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89-96.
18. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006;31:907-912.
19. Piper TM, Rudenstine S, Stancliff S, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J. 2007;4:3.
20. Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82:303-311.
21. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives [published online ahead of print April 21, 2008]. Int J Drug Policy. PMID: 18434126.
22. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008;103:979-989.
23. Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001;322(7291): 895-896.
24. Davis JE. Self-injectable epinephrine for allergic emergencies. J Emerg Med. 2008. Epub ahead of print January 31, 2008. Available at: http://www. sciencedirect.com. Accessed September 21, 2008.
25. Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med. 2007;49(2):172-177.
26. Burris S, Norland J, Edlin BR. Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy. 2001;12:237-248.